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Tuberculous meningitis in a patient 
with acute human immunodeﬁ ciency 
virus infection
The presentation of acute human immunodefi ciency 
virus (HIV) infection is highly variable,1 and may in-
clude aseptic meningitis, meningoencephalitis and 
encephalitis,2–5 which may mask signs of co-existing 
central nervous system infections such as tuberculous 
meningitis.
A 44-year-old woman was admitted to our de-
partment for fever, confusion and diffi culty walking. 
Fifteen days before, she had been admitted to an-
other hospital with fever, rash and confusion, and 
rapidly improved. Brain computed tomography (CT) 
scan was normal and cerebrospinal fl uid (CSF) re-
vealed 100 white blood cells (WBC)/mm3 (90% lym-
phocytes), glucose 50 mg/dl (blood glucose was nor-
mal) and proteins 103 mg/dl. Microscopy and culture 
were negative. She received empiric antiviral and an-
tibiotic therapy and was discharged 10 days later 
with a diagnosis of viral meningitis (IgM antibodies 
[Ab] for Coxsackie virus were positive). As her con-
dition worsened, she was re-admitted to our service, 
where brain CT scan showed diffuse left thalamic hypo-
density and left cortical sulci oedema; CSF revealed 
increased protein value (179 mg/dl), 179 WBC/mm3 
(85% lymphocytes), and negative microscopy. CSF 
glucose value was 58 mg/dl (blood glucose was nor-
mal). Polymerase chain reaction for herpes simplex 
virus and M. tuberculosis in CSF were negative. 
After obtaining the patient’s consent, tests for HIV 
were performed: Western blot was indeterminate, with 
a positive band for gp 120/160 only, but plasma HIV-
RNA level was 40 000 cp/ml and CD4 cell 426/mm3. 
Her husband had used intravenous drugs 20 years 
earlier and had repeatedly refused to undergo HIV 
testing; later, however, he tested positive. 
A subsequent lumbar puncture showed HIV-RNA 
2400 cp/ml and decreased glucose levels (36 mg/dl). 
Empirical anti-tuberculosis treatment with isonia-
zid, rifampicin, ethambutol and pyrazinamide was 
started. Repeated CD4 count showed a sharp de-
crease (178/mm3) and HIV-RNA a marked increase 
(>500 000 cp/ml). HIV genotype showed the pres-
ence of polymorphisms in the protease region (L63P, 
V77I). Antiretroviral treatment (ART) with tenofovir, 
lamivudine and efavirenz was started. The patient’s 
neuropsychological condition progressively improved; 
brain CT showed a resolution of the earlier lesions 
and subsequent lumbar puncture showed normal pro-
tein and glucose values. CSF culture grew M. tuber-
culosis. Two months later, HIV Western blot was 
positive for all bands, HIV-RNA was undetectable 
and CD4 count had increased to 396 cells/mm3. Anti-
tuberculosis treatment was continued for 12 months, 
always associated with ART. 
Our case establishes the need for HIV testing in 
patients with acute meningoencephalitis and menin-
gitis, even in the absence of a history of risk factors. 
The diagnosis of HIV infection is crucial—for public 
health reasons because counselling reduces the risk of 
transmission, and for individual reasons because early 
ART improves prognosis by slowing the rate of dis-
ease progression. Tuberculous meningoencephalitis 
can complicate acute HIV infection and can be con-
fused with the clinical presentation of HIV meningo-
encephalitis. Co-existence is further complicated by 
the diffi culty in diagnosing tuberculous meningitis, 
and empirical treatment may be warranted. 
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Amikacin-induced hypomagnesaemic 
tetany complicating multidrug-resistant 
tuberculosis treatment 
Amikacin (AM), an aminoglycoside antibiotic, is one 
of the most effi cient second-line injectable drugs avail-
able for treatment of multidrug-resistant tuberculo-
sis (MDR-TB). A treatment duration of 6 months is 
